Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MaaT013
i
Other names:
MaaT013, MaaT 013, fecal microbiota transfer, Autologous fecal microbiota transplant
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
MaaT Pharma
Drug class:
Microbiome modulator
Related drugs:
‹
BMC128 (0)
CJRB-101 (0)
CBM588 (0)
EDP1503 (0)
GB104 (0)
MaaT033 (0)
RBX7455 intratumoral (0)
BMC128 (0)
CJRB-101 (0)
CBM588 (0)
EDP1503 (0)
GB104 (0)
MaaT033 (0)
RBX7455 intratumoral (0)
›
Associations
News
Trials
Filter by
Latest
2years
PICASSO: Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma (clinicaltrials.gov)
P2, N=60, Recruiting, Assistance Publique - Hôpitaux de Paris | Not yet recruiting --> Recruiting
2 years ago
Enrollment open
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta)
|
Opdivo (nivolumab) • Yervoy (ipilimumab) • MaaT013
almost3years
PICASSO: Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma (clinicaltrials.gov)
P2, N=60, Not yet recruiting, Assistance Publique - Hôpitaux de Paris
almost 3 years ago
Clinical • New P2 trial
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta)
|
Opdivo (nivolumab) • Yervoy (ipilimumab) • MaaT013
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login